Global Immunoassay Systems Industry

NEW YORK, Sept. 7, 2020 /PRNewswire/ -- Amid the COVID-19 crisis, the global market for Immunoassay Systems estimated at US$21.7 Billion in the year 2020, is projected to reach a revised size of US$29.4 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Enzyme Immunoassay, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$8.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemiluminescence Immunoassay segment is readjusted to a revised 5% CAGR for the next 7-year period.

Read the full report: https://www.reportlinker.com/p05442592/?utm_source=PRN

The U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Grow at 7.8% CAGR

The Immunoassay Systems market in the U.S. is estimated at US$5.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2027 trailing a CAGR of 7.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.5% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Rapid Tests Segment to Record 5.2% CAGR

In the global Rapid Tests segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.2 Billion by the year 2027, while Latin America will expand at a 6.2% CAGR through the analysis period. We bring years of research experience to this 17th edition of our report. The 218-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Abbott Laboratories
• Beckman Coulter Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A
• Ortho-Clinical Diagnostics Inc.
• Quidel Corporation
• Roche Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Tosoh Bioscience Inc.

Read the full report: https://www.reportlinker.com/p05442592/?utm_source=PRN

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Immunoassay Systems: An Introductory Prelude
Recent Market Activity
Steady Growth Projected for World Immunoassay Systems Market
Expanding Applications Boost Market Prospects
Northbound Trajectory in Healthcare Spending Underpins Value
Growth
Developed Regions - Primary Revenue Contributors
Fast Paced Growth Forecasts in Developing Regions
Expansion in Healthcare Infrastructure & Rising Healthcare
Awareness Fuel Demand in Developing Regions
Global Competitor Market Shares
Immunoassay Systems Competitor Market Share Scenario Worldwide
(in %): 2020 & 2029
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Beckman Coulter, Inc. (USA)
bioMérieux SA (France)
Bio-Rad Laboratories Inc. (USA)
DiaSorin S.p.A (Italy)
Fujirebio, Inc. (Japan)
Ortho-Clinical Diagnostics, Inc. (USA)
Quidel Corporation (USA)
Roche Diagnostics (Switzerland)
Siemens Healthineers (USA)
Sysmex Corporation (Japan)
Tosoh Bioscience Inc. (USA)

3. MARKET TRENDS & DRIVERS
Bespoke Solutions Energize Market Growth
Multiplex Immunoassays Accelerate Overall Market Expansion
ELISA - Preferred Immunoassay Test in Research and Diagnostic
Applications
Automation of ELISA - Enabling its Sustenance
Growing Popularity of Multiplexing Deters ELISA Market
Commoditization: A Key Issue Facing ELISA Product Manufacturers
Chemiluminescence Immunoassays Gain Prominence
Waning Demand for Radioimmunoassay Systems
Immunoassays Solidify their Role in Biomarker Detection
SERS - An Attractive Readout Strategy
Automated Immunoassay Systems - In Line with Automation Trend
Point-of-Care (POC) and Digital immunoassay (DIA) Systems Make
Substantial Gains
Miniaturization Aids Roll Out of Sophisticated POC and DIA Systems
Ultra-Sensitive Platforms Set to Proliferate the Market
Infectious Disease Diagnosis - Primary Application Area
Increasing Incidence of Infectious Diseases - An Opportunity
Indicator
Growing Significance in Cancer Care
Sustained Opportunities in Endocrine Testing Procedures
Diabetes Testing
Prenatal Testing
Vital Role in Blood Processing Applications
Blood Grouping and Typing
Food Sciences and Quality Control Offer Robust Growth Verticals
Growing Prominence of Immunoassays in New & Niche Application
Verticals: A Review
Environmental Testing
Drugs of Abuse Testing (DAT)
Therapeutic Drug Monitoring (TDM)
Immune Diseases
Expanding Use Case in Biomedical Research Processes Amplifies
Demand
Consolidation of Hospitals and Labs Triggers Robust Growth
Opportunities
Rising Medical Needs of Aging Population - A Market Driver

4. GLOBAL MARKET PERSPECTIVE
Table 1: Immunoassay Systems Global Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 2: Immunoassay Systems Global Retrospective Market
Scenario in US$ Thousand by Region/Country: 2012-2019

Table 3: Immunoassay Systems Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Enzyme Immunoassay (Technology) World Market by
Region/Country in US$ Thousand: 2020 to 2027

Table 5: Enzyme Immunoassay (Technology) Historic Market
Analysis by Region/Country in US$ Thousand: 2012 to 2019

Table 6: Enzyme Immunoassay (Technology) Market Share Breakdown
of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Chemiluminescence Immunoassay (Technology) Potential
Growth Markets Worldwide in US$ Thousand: 2020 to 2027

Table 8: Chemiluminescence Immunoassay (Technology) Historic
Market Perspective by Region/Country in US$ Thousand: 2012 to
2019

Table 9: Chemiluminescence Immunoassay (Technology) Market
Sales Breakdown by Region/Country in Percentage: 2012 VS 2020
VS 2027

Table 10: Rapid Tests (Technology) Geographic Market Spread
Worldwide in US$ Thousand: 2020 to 2027

Table 11: Rapid Tests (Technology) Region Wise Breakdown of
Global Historic Demand in US$ Thousand: 2012 to 2019

Table 12: Rapid Tests (Technology) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Fluorescence Immunoassay (Technology) World Market
Estimates and Forecasts by Region/Country in US$ Thousand: 2020
to 2027

Table 14: Fluorescence Immunoassay (Technology) Market Historic
Review by Region/Country in US$ Thousand: 2012 to 2019

Table 15: Fluorescence Immunoassay (Technology) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 16: ELISPOT (Technology) World Market by Region/Country
in US$ Thousand: 2020 to 2027

Table 17: ELISPOT (Technology) Historic Market Analysis by
Region/Country in US$ Thousand: 2012 to 2019

Table 18: ELISPOT (Technology) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 19: PCR (Technology) World Market Estimates and Forecasts
in US$ Thousand by Region/Country: 2020 to 2027

Table 20: PCR (Technology) Market Worldwide Historic Review by
Region/Country in US$ Thousand: 2012 to 2019

Table 21: PCR (Technology) Market Percentage Share Distribution
by Region/Country: 2012 VS 2020 VS 2027

Table 22: Other Technologies (Technology) Market Opportunity
Analysis Worldwide in US$ Thousand by Region/Country: 2020 to
2027

Table 23: Other Technologies (Technology) Global Historic
Demand in US$ Thousand by Region/Country: 2012 to 2019

Table 24: Other Technologies (Technology) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Immunoassay Systems Market Share (in %) by Company: 2020 & 2025
Market Analytics
Table 25: Immunoassay Systems Market in US$ Thousand in the
United States by Technology: 2020-2027

Table 26: United States Immunoassay Systems Market
Retrospective Analysis in US$ Thousand by Technology: 2012-2019

Table 27: United States Immunoassay Systems Market Share
Breakdown by Technology: 2012 VS 2020 VS 2027

CANADA
Table 28: Immunoassay Systems Market Analysis in Canada in US$
Thousand by Technology: 2020-2027

Table 29: Immunoassay Systems Market in Canada: Historic Review
in US$ Thousand by Technology for the Period 2012-2019

Table 30: Canadian Immunoassay Systems Market Share Breakdown
by Technology: 2012 VS 2020 VS 2027

JAPAN
Table 31: Japanese Medium & Long-Term Outlook for Immunoassay
Systems Market in US$ Thousand by Technology: 2020-2027

Table 32: Immunoassay Systems Market in Japan in US$ Thousand
by Technology: 2012-2019

Table 33: Japanese Immunoassay Systems Market Percentage Share
Distribution by Technology: 2012 VS 2020 VS 2027

CHINA
Table 34: Immunoassay Systems Market Estimates and Forecasts in
China in US$ Thousand by Technology: 2020-2027

Table 35: Chinese Immunoassay Systems Retrospective Market
Scenario in US$ Thousand by Technology: 2012-2019

Table 36: Immunoassay Systems Market in China: Percentage Share
Analysis by Technology for 2012, 2020, and 2027

EUROPE
Market Facts & Figures
European Immunoassay Systems Market: Competitor Market Share
Scenario (in %) for 2020 & 2025
Market Analytics
Table 37: European Immunoassay Systems Market Demand Scenario
in US$ Thousand by Region/Country: 2020-2027

Table 38: Immunoassay Systems Market in Europe: A Historic
Market Perspective in US$ Thousand by Region/Country for the
Period 2012-2019

Table 39: European Immunoassay Systems Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 40: European Immunoassay Systems Market Assessment in US$
Thousand by Technology: 2020-2027

Table 41: European Immunoassay Systems Historic Market Review
in US$ Thousand by Technology: 2012-2019

Table 42: Immunoassay Systems Market in Europe: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027

FRANCE
Table 43: French Immunoassay Systems Market Estimates and
Projections in US$ Thousand by Technology: 2020-2027

Table 44: French Immunoassay Systems Historic Market Analysis
in US$ Thousand by Technology: 2012-2019

Table 45: French Immunoassay Systems Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027

GERMANY
Table 46: German Immunoassay Systems Latent Demand Forecasts in
US$ Thousand by Technology: 2020-2027

Table 47: Immunoassay Systems Market in Germany: A Historic
Perspective by Technology in US$ Thousand for the Period
2012-2019

Table 48: German Immunoassay Systems Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027

ITALY
Table 49: Immunoassay Systems Market Estimates and Forecasts in
Italy in US$ Thousand by Technology: 2020-2027

Table 50: Italian Immunoassay Systems Retrospective Market
Scenario in US$ Thousand by Technology: 2012-2019

Table 51: Immunoassay Systems Market in Italy: Percentage Share
Analysis by Technology for 2012, 2020, and 2027

UNITED KINGDOM
Table 52: United Kingdom Medium & Long-Term Outlook for
Immunoassay Systems Market in US$ Thousand by Technology:
2020-2027

Table 53: Immunoassay Systems Market in the United Kingdom in
US$ Thousand by Technology: 2012-2019

Table 54: United Kingdom Immunoassay Systems Market Percentage
Share Distribution by Technology: 2012 VS 2020 VS 2027

SPAIN
Table 55: Immunoassay Systems Market Analysis in Spain in US$
Thousand by Technology: 2020-2027

Table 56: Immunoassay Systems Market in Spain: Historic Review
in US$ Thousand by Technology for the Period 2012-2019

Table 57: Spanish Immunoassay Systems Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027

RUSSIA
Table 58: Immunoassay Systems Market in US$ Thousand in Russia
by Technology: 2020-2027

Table 59: Russian Immunoassay Systems Market Retrospective
Analysis in US$ Thousand by Technology: 2012-2019

Table 60: Russian Immunoassay Systems Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 61: Rest of Europe Immunoassay Systems Market Assessment
in US$ Thousand by Technology: 2020-2027

Table 62: Rest of Europe Immunoassay Systems Historic Market
Review in US$ Thousand by Technology: 2012-2019

Table 63: Immunoassay Systems Market in Rest of Europe:
Percentage Breakdown of Sales by Technology for 2012, 2020, and
2027

ASIA-PACIFIC
Table 64: Asia-Pacific Immunoassay Systems Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 65: Immunoassay Systems Market in Asia-Pacific: Historic
Market Analysis in US$ Thousand by Region/Country for the
Period 2012-2019

Table 66: Asia-Pacific Immunoassay Systems Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 67: Asia-Pacific Immunoassay Systems Market Estimates and
Projections in US$ Thousand by Technology: 2020-2027

Table 68: Asia-Pacific Immunoassay Systems Historic Market
Analysis in US$ Thousand by Technology: 2012-2019

Table 69: Asia-Pacific Immunoassay Systems Historic Market
Analysis in US$ Thousand by Technology: 2012 VS 2020 VS 2027

AUSTRALIA
Table 70: Australian Immunoassay Systems Latent Demand
Forecasts in US$ Thousand by Technology: 2020-2027

Table 71: Immunoassay Systems Market in Australia: A Historic
Perspective by Technology in US$ Thousand for the Period
2012-2019

Table 72: Australian Immunoassay Systems Market Share Breakdown
by Technology: 2012 VS 2020 VS 2027

INDIA
Table 73: Immunoassay Systems Market Analysis in India in US$
Thousand by Technology: 2020-2027

Table 74: Immunoassay Systems Market in India: Historic Review
in US$ Thousand by Technology for the Period 2012-2019

Table 75: Indian Immunoassay Systems Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 76: Immunoassay Systems Market in South Korea: Recent
Past, Current and Future Analysis in US$ Thousand by Technology
for the Period 2020-2027

Table 77: South Korean Immunoassay Systems Historic Market
Analysis in US$ Thousand by Technology: 2012-2019

Table 78: Immunoassay Systems Market Share Distribution in
South Korea by Technology: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 79: Rest of Asia-Pacific Medium & Long-Term Outlook for
Immunoassay Systems Market in US$ Thousand by Technology:
2020-2027

Table 80: Immunoassay Systems Market in Rest of Asia-Pacific in
US$ Thousand by Technology: 2012-2019

Table 81: Rest of Asia-Pacific Immunoassay Systems Market
Percentage Share Distribution by Technology: 2012 VS 2020 VS
2027

LATIN AMERICA
Table 82: Latin American Immunoassay Systems Market Trends by
Region/Country in US$ Thousand: 2020-2027

Table 83: Immunoassay Systems Market in Latin America in US$
Thousand by Region/Country: A Historic Perspective for the
Period 2012-2019

Table 84: Latin American Immunoassay Systems Market Percentage
Breakdown of Sales by Region/Country: 2012, 2020, and 2027

Table 85: Immunoassay Systems Market Estimates and Forecasts in
Latin America in US$ Thousand by Technology: 2020-2027

Table 86: Latin American Immunoassay Systems Retrospective
Market Scenario in US$ Thousand by Technology: 2012-2019

Table 87: Immunoassay Systems Market in Latin America :
Percentage Analysis by Technology for 2012, 2020, and 2027

ARGENTINA
Table 88: Argentinean Immunoassay Systems Market Assessment in
US$ Thousand by Technology: 2020-2027

Table 89: Argentinean Immunoassay Systems Historic Market
Review in US$ Thousand by Technology: 2012-2019

Table 90: Immunoassay Systems Market in Argentina: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027

BRAZIL
Table 91: Brazilian Immunoassay Systems Market Estimates and
Projections in US$ Thousand by Technology: 2020-2027

Table 92: Brazilian Immunoassay Systems Historic Market
Analysis in US$ Thousand by Technology: 2012-2019

Table 93: Brazilian Immunoassay Systems Market Share Breakdown
by Technology: 2012 VS 2020 VS 2027

MEXICO
Table 94: Mexican Immunoassay Systems Latent Demand Forecasts
in US$ Thousand by Technology: 2020-2027

Table 95: Immunoassay Systems Market in Mexico: A Historic
Perspective by Technology in US$ Thousand for the Period
2012-2019

Table 96: Mexican Immunoassay Systems Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 97: Immunoassay Systems Market in US$ Thousand in Rest of
Latin America by Technology: 2020-2027

Table 98: Rest of Latin America Immunoassay Systems Market
Retrospective Analysis in US$ Thousand by Technology: 2012-2019

Table 99: Rest of Latin America Immunoassay Systems Market
Share Breakdown by Technology: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 100: The Middle East Immunoassay Systems Market Estimates
and Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 101: Immunoassay Systems Market in the Middle East by
Region/Country in US$ Thousand: 2012-2019

Table 102: The Middle East Immunoassay Systems Market Share
Breakdown by Region/Country: 2012, 2020, and 2027

Table 103: The Middle East Immunoassay Systems Market Analysis
in US$ Thousand by Technology: 2020-2027

Table 104: Immunoassay Systems Market in the Middle East:
Historic Review in US$ Thousand by Technology for the Period
2012-2019

Table 105: The Middle East Immunoassay Systems Market Share
Breakdown by Technology: 2012 VS 2020 VS 2027

IRAN
Table 106: Iranian Medium & Long-Term Outlook for Immunoassay
Systems Market in US$ Thousand by Technology: 2020-2027

Table 107: Immunoassay Systems Market in Iran in US$ Thousand
by Technology: 2012-2019

Table 108: Iranian Immunoassay Systems Market Percentage Share
Distribution by Technology: 2012 VS 2020 VS 2027

ISRAEL
Table 109: Israeli Immunoassay Systems Market Assessment in US$
Thousand by Technology: 2020-2027

Table 110: Israeli Immunoassay Systems Historic Market Review
in US$ Thousand by Technology: 2012-2019

Table 111: Immunoassay Systems Market in Israel: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027

SAUDI ARABIA
Table 112: Immunoassay Systems Market Estimates and Forecasts
in Saudi Arabia in US$ Thousand by Technology: 2020-2027

Table 113: Saudi Arabian Immunoassay Systems Retrospective
Market Scenario in US$ Thousand by Technology: 2012-2019

Table 114: Immunoassay Systems Market in Saudi Arabia:
Percentage Share Analysis by Technology for 2012, 2020, and
2027

UNITED ARAB EMIRATES
Table 115: Immunoassay Systems Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Technology for the Period 2020-2027

Table 116: United Arab Emirates Immunoassay Systems Historic
Market Analysis in US$ Thousand by Technology: 2012-2019

Table 117: Immunoassay Systems Market Share Distribution in
United Arab Emirates by Technology: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST
Table 118: Rest of Middle East Immunoassay Systems Latent
Demand Forecasts in US$ Thousand by Technology: 2020-2027

Table 119: Immunoassay Systems Market in Rest of Middle East:
A Historic Perspective by Technology in US$ Thousand for the
Period 2012-2019

Table 120: Rest of Middle East Immunoassay Systems Market Share
Breakdown by Technology: 2012 VS 2020 VS 2027

AFRICA
Table 121: Immunoassay Systems Market in US$ Thousand in Africa
by Technology: 2020-2027

Table 122: African Immunoassay Systems Market Retrospective
Analysis in US$ Thousand by Technology: 2012-2019

Table 123: African Immunoassay Systems Market Share Breakdown
by Technology: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 65
Read the full report: https://www.reportlinker.com/p05442592/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]  
US: (339)-368-6001
Intl: +1-339-368-6001

SOURCE Reportlinker

Related Links

www.reportlinker.com